日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer.

TC2N 是一种新型癌基因,它通过抑制肺癌中的 p53 信号通路来加速肿瘤进展

Hao Xiang-Lin, Han Fei, Zhang Ning, Chen Hong-Qiang, Jiang Xiao, Yin Li, Liu Wen-Bin, Wang Dan-Dan, Chen Jian-Ping, Cui Zhi-Hong, Ao Lin, Cao Jia, Liu Jin-Yi

Author Correction: Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer

作者更正:鉴定出TC2N是乳腺癌中PI3K-AKT信号通路的一种新型潜在抑制剂

Hao, Xiang-Lin; Gao, Li-Yun; Deng, Xiao-Juan; Han, Fei; Chen, Hong-Qiang; Jiang, Xiao; Liu, Wen-Bin; Wang, Dan-Dan; Chen, Jian-Ping; Cui, Zhi-Hong; Ao, Lin; Cao, Jia; Liu, Jin-Yi

Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer

TC2N被鉴定为乳腺癌中PI3K-AKT信号通路的一种新型有前景的抑制因子

Hao, Xiang-Lin; Gao, Li-Yun; Deng, Xiao-Juan; Han, Fei; Chen, Hong-Qiang; Jiang, Xiao; Liu, Wen-Bin; Wang, Dan-Dan; Chen, Jian-Ping; Cui, Zhi-Hong; Ao, Lin; Cao, Jia; Liu, Jin-Yi

Diagnostic and prognostic value of the BEX family in lung adenocarcinoma

BEX家族在肺腺癌诊断和预后中的价值

Zhang, Zhong-Hao; Luan, Zhi-Yu; Han, Fei; Chen, Hong-Qiang; Liu, Wen-Bin; Liu, Jin-Yi; Cao, Jia

Copy number variations and expression of MPDZ are prognostic biomarkers for clear cell renal cell carcinoma

MPDZ拷贝数变异和表达是透明细胞肾细胞癌的预后生物标志物。

Huang, Yong-Sheng; Liu, Wen-Bin; Han, Fei; Yang, Jun-Tang; Hao, Xiang-Lin; Chen, Hong-Qiang; Jiang, Xiao; Yin, Li; Ao, Lin; Cui, Zhi-Hong; Cao, Jia; Liu, Jin-Yi

TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer.

TMEM196 是一种新型功能性肿瘤抑制因子,可通过 DNA 甲基化失活,是肺癌的潜在预后生物标志物

Liu Wen-bin, Han Fei, Jiang Xiao, Chen Hong-qiang, Zhao Huan, Liu Yong, Li Yong-hong, Huang Chuanshu, Cao Jia, Liu Jin-yi